List of Tables
Table 1. Clinical Oncology Next Generation Sequencing Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Clinical Oncology Next Generation Sequencing Market Trends
Table 3. Clinical Oncology Next Generation Sequencing Market Drivers
Table 4. Clinical Oncology Next Generation Sequencing Market Challenges
Table 5. Clinical Oncology Next Generation Sequencing Market Restraints
Table 6. Global Clinical Oncology Next Generation Sequencing Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Clinical Oncology Next Generation Sequencing Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Clinical Oncology Next Generation Sequencing Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Clinical Oncology Next Generation Sequencing Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Clinical Oncology Next Generation Sequencing Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Clinical Oncology Next Generation Sequencing Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Clinical Oncology Next Generation Sequencing Revenue Share by Player, 2017-2022
Table 13. Global Clinical Oncology Next Generation Sequencing Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Clinical Oncology Next Generation Sequencing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Oncology Next Generation Sequencing as of 2021)
Table 15. Top Players of Clinical Oncology Next Generation Sequencing in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Clinical Oncology Next Generation Sequencing Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Clinical Oncology Next Generation Sequencing Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Clinical Oncology Next Generation Sequencing Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Clinical Oncology Next Generation Sequencing Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Clinical Oncology Next Generation Sequencing Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Clinical Oncology Next Generation Sequencing Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Clinical Oncology Next Generation Sequencing Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Clinical Oncology Next Generation Sequencing Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Clinical Oncology Next Generation Sequencing Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Clinical Oncology Next Generation Sequencing Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Clinical Oncology Next Generation Sequencing Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Clinical Oncology Next Generation Sequencing Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Clinical Oncology Next Generation Sequencing Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Illumina, Inc. Company Details
Table 31. Illumina, Inc. Business Overview
Table 32. Illumina, Inc. Clinical Oncology Next Generation Sequencing Product
Table 33. Illumina, Inc. Revenue in Clinical Oncology Next Generation Sequencing Business (2017-2022) & (US$ Million)
Table 34. Illumina, Inc. Recent Development
Table 35. Thermo Fisher Scientific Company Details
Table 36. Thermo Fisher Scientific Business Overview
Table 37. Thermo Fisher Scientific Clinical Oncology Next Generation Sequencing Product
Table 38. Thermo Fisher Scientific Revenue in Clinical Oncology Next Generation Sequencing Business (2017-2022) & (US$ Million)
Table 39. Thermo Fisher Scientific Recent Development
Table 40. F. Hoffmann-La Roche Ltd. Company Details
Table 41. F. Hoffmann-La Roche Ltd. Business Overview
Table 42. F. Hoffmann-La Roche Ltd. Clinical Oncology Next Generation Sequencing Product
Table 43. F. Hoffmann-La Roche Ltd. Revenue in Clinical Oncology Next Generation Sequencing Business (2017-2022) & (US$ Million)
Table 44. F. Hoffmann-La Roche Ltd. Recent Development
Table 45. Agilent Technologies Company Details
Table 46. Agilent Technologies Business Overview
Table 47. Agilent Technologies Clinical Oncology Next Generation Sequencing Product
Table 48. Agilent Technologies Revenue in Clinical Oncology Next Generation Sequencing Business (2017-2022) & (US$ Million)
Table 49. Agilent Technologies Recent Development
Table 50. Myriad Genetics Company Details
Table 51. Myriad Genetics Business Overview
Table 52. Myriad Genetics Clinical Oncology Next Generation Sequencing Product
Table 53. Myriad Genetics Revenue in Clinical Oncology Next Generation Sequencing Business (2017-2022) & (US$ Million)
Table 54. Myriad Genetics Recent Development
Table 55. Beijing Genomics Institute (BGI) Company Details
Table 56. Beijing Genomics Institute (BGI) Business Overview
Table 57. Beijing Genomics Institute (BGI) Clinical Oncology Next Generation Sequencing Product
Table 58. Beijing Genomics Institute (BGI) Revenue in Clinical Oncology Next Generation Sequencing Business (2017-2022) & (US$ Million)
Table 59. Beijing Genomics Institute (BGI) Recent Development
Table 60. Perkin Elmer Company Details
Table 61. Perkin Elmer Business Overview
Table 62. Perkin Elmer Clinical Oncology Next Generation Sequencing Product
Table 63. Perkin Elmer Revenue in Clinical Oncology Next Generation Sequencing Business (2017-2022) & (US$ Million)
Table 64. Perkin Elmer Recent Development
Table 65. Foundation Medicine Company Details
Table 66. Foundation Medicine Business Overview
Table 67. Foundation Medicine Clinical Oncology Next Generation Sequencing Product
Table 68. Foundation Medicine Revenue in Clinical Oncology Next Generation Sequencing Business (2017-2022) & (US$ Million)
Table 69. Foundation Medicine Recent Development
Table 70. Pacific Bioscience Company Details
Table 71. Pacific Bioscience Business Overview
Table 72. Pacific Bioscience Clinical Oncology Next Generation Sequencing Product
Table 73. Pacific Bioscience Revenue in Clinical Oncology Next Generation Sequencing Business (2017-2022) & (US$ Million)
Table 74. Pacific Bioscience Recent Development
Table 75. Oxford Nanopore Technologies Ltd. Company Details
Table 76. Oxford Nanopore Technologies Ltd. Business Overview
Table 77. Oxford Nanopore Technologies Ltd. Clinical Oncology Next Generation Sequencing Product
Table 78. Oxford Nanopore Technologies Ltd. Revenue in Clinical Oncology Next Generation Sequencing Business (2017-2022) & (US$ Million)
Table 79. Oxford Nanopore Technologies Ltd. Recent Development
Table 80. Paradigm Diagnostics Company Details
Table 81. Paradigm Diagnostics Business Overview
Table 82. Paradigm Diagnostics Clinical Oncology Next Generation Sequencing Product
Table 83. Paradigm Diagnostics Revenue in Clinical Oncology Next Generation Sequencing Business (2017-2022) & (US$ Million)
Table 84. Paradigm Diagnostics Recent Development
Table 85. Caris Life Sciences Company Details
Table 86. Caris Life Sciences Business Overview
Table 87. Caris Life Sciences Clinical Oncology Next Generation Sequencing Product
Table 88. Caris Life Sciences Revenue in Clinical Oncology Next Generation Sequencing Business (2017-2022) & (US$ Million)
Table 89. Caris Life Sciences Recent Development
Table 90. Partek, Inc. Company Details
Table 91. Partek, Inc. Business Overview
Table 92. Partek, Inc. Clinical Oncology Next Generation Sequencing Product
Table 93. Partek, Inc. Revenue in Clinical Oncology Next Generation Sequencing Business (2017-2022) & (US$ Million)
Table 94. Partek, Inc. Recent Development
Table 95. Eurofins Scientific S.E. Company Details
Table 96. Eurofins Scientific S.E. Business Overview
Table 97. Eurofins Scientific S.E. Clinical Oncology Next Generation Sequencing Product
Table 98. Eurofins Scientific S.E. Revenue in Clinical Oncology Next Generation Sequencing Business (2017-2022) & (US$ Million)
Table 99. Eurofins Scientific S.E. Recent Development
Table 100. Qiagen N.V. Company Details
Table 101. Qiagen N.V. Business Overview
Table 102. Qiagen N.V. Clinical Oncology Next Generation Sequencing Product
Table 103. Qiagen N.V. Revenue in Clinical Oncology Next Generation Sequencing Business (2017-2022) & (US$ Million)
Table 104. Qiagen N.V. Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Clinical Oncology Next Generation Sequencing Product Picture
Figure 2. Global Clinical Oncology Next Generation Sequencing Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Clinical Oncology Next Generation Sequencing Market Size 2017-2028 (US$ Million)
Figure 4. United States Clinical Oncology Next Generation Sequencing Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Clinical Oncology Next Generation Sequencing Market Size 2017-2028 (US$ Million)
Figure 6. United States Clinical Oncology Next Generation Sequencing Market Share in Global 2017-2028
Figure 7. Clinical Oncology Next Generation Sequencing Report Years Considered
Figure 8. Product Picture of Whole Genome Sequencing
Figure 9. Product Picture of Whole Exome Sequencing
Figure 10. Product Picture of Targeted Sequencing & Resequencing Centrifuges
Figure 11. Global Clinical Oncology Next Generation Sequencing Market Share by Type in 2022 & 2028
Figure 12. Global Clinical Oncology Next Generation Sequencing Market Size by Type (2017-2028) & (US$ Million)
Figure 13. Global Clinical Oncology Next Generation Sequencing Market Share by Type (2017-2028)
Figure 14. United States Clinical Oncology Next Generation Sequencing Market Share by Type in 2022 & 2028
Figure 15. United States Clinical Oncology Next Generation Sequencing Market Size by Type (2017-2028) & (US$ Million)
Figure 16. United States Clinical Oncology Next Generation Sequencing Market Share by Type (2017-2028)
Figure 17. Product Picture of Hospitals
Figure 18. Product Picture of Clinics
Figure 19. Product Picture of Laboratories
Figure 20. Global Clinical Oncology Next Generation Sequencing Market Share by Application in 2022 & 2028
Figure 21. Global Clinical Oncology Next Generation Sequencing Market Size by Application (2017-2028) & (US$ Million)
Figure 22. Global Clinical Oncology Next Generation Sequencing Market Share by Application (2017-2028)
Figure 23. United States Clinical Oncology Next Generation Sequencing Market Share by Application in 2022 & 2028
Figure 24. United States Clinical Oncology Next Generation Sequencing Market Size by Application (2017-2028) & (US$ Million)
Figure 25. United States Clinical Oncology Next Generation Sequencing Market Share by Application (2017-2028)
Figure 26. North America Clinical Oncology Next Generation Sequencing Market Size Growth Rate 2017-2028 (US$ Million)
Figure 27. U.S. Clinical Oncology Next Generation Sequencing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 28. Canada Clinical Oncology Next Generation Sequencing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 29. Europe Clinical Oncology Next Generation Sequencing Market Size Growth Rate 2017-2028 (US$ Million)
Figure 30. Germany Clinical Oncology Next Generation Sequencing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. France Clinical Oncology Next Generation Sequencing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. U.K. Clinical Oncology Next Generation Sequencing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. Italy Clinical Oncology Next Generation Sequencing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Russia Clinical Oncology Next Generation Sequencing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Clinical Oncology Next Generation Sequencing Market Size Growth Rate 2017-2028 (US$ Million)
Figure 36. China Clinical Oncology Next Generation Sequencing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. Japan Clinical Oncology Next Generation Sequencing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. South Korea Clinical Oncology Next Generation Sequencing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. India Clinical Oncology Next Generation Sequencing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. Australia Clinical Oncology Next Generation Sequencing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. China Taiwan Clinical Oncology Next Generation Sequencing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Indonesia Clinical Oncology Next Generation Sequencing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Thailand Clinical Oncology Next Generation Sequencing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Malaysia Clinical Oncology Next Generation Sequencing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Latin America Clinical Oncology Next Generation Sequencing Market Size Growth Rate 2017-2028 (US$ Million)
Figure 46. Mexico Clinical Oncology Next Generation Sequencing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Brazil Clinical Oncology Next Generation Sequencing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Argentina Clinical Oncology Next Generation Sequencing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size Growth Rate 2017-2028 (US$ Million)
Figure 50. Turkey Clinical Oncology Next Generation Sequencing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Saudi Arabia Clinical Oncology Next Generation Sequencing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. UAE Clinical Oncology Next Generation Sequencing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. Illumina, Inc. Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2017-2022)
Figure 54. Thermo Fisher Scientific Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2017-2022)
Figure 55. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2017-2022)
Figure 56. Agilent Technologies Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2017-2022)
Figure 57. Myriad Genetics Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2017-2022)
Figure 58. Beijing Genomics Institute (BGI) Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2017-2022)
Figure 59. Perkin Elmer Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2017-2022)
Figure 60. Foundation Medicine Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2017-2022)
Figure 61. Pacific Bioscience Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2017-2022)
Figure 62. Oxford Nanopore Technologies Ltd. Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2017-2022)
Figure 63. Paradigm Diagnostics Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2017-2022)
Figure 64. Caris Life Sciences Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2017-2022)
Figure 65. Partek, Inc. Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2017-2022)
Figure 66. Eurofins Scientific S.E. Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2017-2022)
Figure 67. Qiagen N.V. Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2017-2022)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
